 |
 |
 |
| |
Adherence and Persistence in US Real-World New PrEP Users: Cabotegravir (CAB-LA) vs Oral PrEP
|
| |
| |
CROI 2026 Feb 22-25 Denver
Aimee A. Metzner,1 Catherine Nguyen,2 Farbod Alinezhad,3 Azeem Banatwala,2 Leili Young-Xu,3 Gabrielle Herman,1 Dora Martinez,1 Shana Walko,1 Maral DerSarkissian2
1ViiV Healthcare, Durham, NC, USA; 2Analysis Group, Inc, Los Angeles, CA, USA; 3Analysis Group, Inc, Boston, MA, USA






|
| |
|
 |
 |
|
|